医药周观点:“医保商保双目录”正式发布 重视创新药及相关产业链投资机会

信达证券
Dec 08

市场表现:上周医药生物板块收益率为-0.74%,板块相对沪深 300 收益率为-2.02%,在31 个一级子行业指数中涨跌幅排名第21。6 个子板块中,医药商业板块周收益率排名第一,涨跌幅为5.19%(相对沪深300 收益率为3.91%);收益率排名第六的为医疗服务,涨跌幅为-1.37%(相对沪深300 收益率为-2.65%)。周观点:目前市场短期缺乏明确的主线,上周领涨的子板块为医药商业,而领涨...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10